Two people have died after a plane crashed into vehicles on a busy road in the Brazilian city of Sao Paulo. A fire department spokesperson confirmed the deaths, after two bodies were found in the ...

An air ambulance charity has expanded its vehicle fleet after its "busiest year" on record. Magpas Air Ambulance hoped the addition of three new rapid response vehicles could help it meet a ...

Still, the busy couple have found a way to balance their ever-changing personal and professional lives. "We don't travel as much with the girls," Jason tells PEOPLE. "We go back and forth because ...

Investors might want to bet on Supernus Pharmaceuticals (SUPN), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

PHOENIX (AZFamily) — A busy road is closed after a man was struck by a vehicle in the midst of Phoenix rush hour early Wednesday morning. Authorities say the collision happened just before 6:30 ...

Supernus Pharmaceuticals' ONAPGO for Parkinson’s Disease received FDA approval, providing a basis for optimism despite past regulatory challenges with SPN-830. The company is methodically ...

Supernus (SUPN) Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, approved ONAPGO injection, formerly known as SPN-830, as the first and only subcutaneous apomorphine ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been ...

Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's ...

A new Supernus Pharmaceuticals medical device that continuously administers an old Parkinson’s disease drug is now FDA approved, giving patients another way to manage the motor control symptoms ...